Victory Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.3K Sell
28,207
-567,775
-95% -$1.8M ﹤0.01% 2287
2025
Q4
$2.21M Buy
595,982
+169,116
+40% +$546K ﹤0.01% 1563
2025
Q3
$1.13M Buy
426,866
+403,664
+1,740% +$781K ﹤0.01% 1781
2025
Q2
$22.8K Sell
23,202
-420
-2% -$421 ﹤0.01% 2436
2025
Q1
$34K Sell
23,622
-149,461
-86% -$275K ﹤0.01% 2393
2024
Q4
$381K Buy
173,083
+148,456
+603% +$346K ﹤0.01% 2097
2024
Q3
$40.6K Buy
24,627
+2,417
+11% +$4.88K ﹤0.01% 2403
2024
Q2
$49.3K Sell
22,210
-1,969
-8% -$4.63K ﹤0.01% 2370
2024
Q1
$64.8K Buy
24,179
+8,981
+59% +$21.8K ﹤0.01% 2354
2023
Q4
$45.4K Buy
15,198
+3,558
+31% +$4.62K ﹤0.01% 2448
2023
Q3
$11.4K Buy
11,640
+1,372
+13% +$1.99K ﹤0.01% 2478
2023
Q2
$14.3K Buy
+10,268
New +$14.3K ﹤0.01% 2470
2021
Q3
Sell
-17,390
Closed -$368K 2794
2021
Q2
$368K Sell
17,390
-689
-4% -$16.6K ﹤0.01% 2346
2021
Q1
$507K Sell
18,079
-816
-4% -$24.1K ﹤0.01% 2199
2020
Q4
$491K Sell
18,895
-929
-5% -$27.8K ﹤0.01% 2088
2020
Q3
$737K Sell
19,824
-7,290
-27% -$289K ﹤0.01% 1831
2020
Q2
$1.39M Buy
27,114
+138
+0.5% +$5.77K ﹤0.01% 1570
2020
Q1
$850K Buy
26,976
+12,067
+81% +$637K ﹤0.01% 1906
2019
Q4
$889K Buy
14,909
+707
+5% +$31.8K ﹤0.01% 1786
2019
Q3
$521K Buy
14,202
+13,929
+5,102% +$552K ﹤0.01% 1868
2019
Q2
$13K Hold
273
﹤0.01% 1802
2019
Q1
$11K Hold
273
﹤0.01% 1762
2018
Q4
$13K Sell
273
-52
-16% -$2.5K ﹤0.01% 1754
2018
Q3
$14K Buy
325
+43
+15% +$1.97K ﹤0.01% 1777
2018
Q2
$11K Hold
282
﹤0.01% 1809
2018
Q1
$20K Hold
282
﹤0.01% 1790
2017
Q4
$19K Hold
282
﹤0.01% 1789
2017
Q3
$14K Hold
282
﹤0.01% 1794
2017
Q2
$13K Buy
282
+5
+2% +$184 ﹤0.01% 1790
2017
Q1
$10K Hold
277
﹤0.01% 1789
2016
Q4
$3K Buy
277
+17
+7% +$202 ﹤0.01% 1787
2016
Q3
$4K Buy
260
+18
+7% +$204 ﹤0.01% 1772
2016
Q2
$2K Buy
242
+5
+2% +$83 ﹤0.01% 1630
2016
Q1
$4K Buy
237
+18
+8% +$290 ﹤0.01% 1656
2015
Q4
$5K Buy
219
+12
+6% +$303 ﹤0.01% 1672
2015
Q3
$5K Buy
207
+20
+11% +$1.25K ﹤0.01% 1613
2015
Q2
$15K Buy
+187
New +$18.3K ﹤0.01% 1608

Other funds holding ESPR